Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis (REACT-CF)

NCT03078127 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT03078127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Researching the Effects of Airway Clearance Therapies in Cystic Fibrosis (REACT-CF)
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2017
Completion date
January 10, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, mucociliary clearance defect